Mesalazine 1.2 TAKEDA  (mesalazine) 1.2 g  prolonged release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

mesalazine 1.2 takeda (mesalazine) 1.2 g prolonged release tablet blister pack

takeda pharmaceuticals australia pty ltd - mesalazine, quantity: 1200 mg - tablet, modified release - excipient ingredients: methacrylic acid copolymer; purified talc; silicon dioxide; sodium starch glycollate; stearic acid; iron oxide red; carmellose sodium; carnauba wax; magnesium stearate; titanium dioxide; macrogol 6000; triethyl citrate - for the induction and maintenance of remission in patients with mild to moderate, active ulcerative colitis.

Asacol New Zealand - English - Medsafe (Medicines Safety Authority)

asacol

chiesi new zealand limited t/a emerge health - mesalazine 400mg - enteric coated tablet - 400 mg - active: mesalazine 400mg excipient: iron oxide red iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate methacrylic acid copolymer povidone purified talc   sodium starch glycolate triethyl citrate - induction of remission of mild to moderate episodes of ulcerative colitis. maintenance of remission of ulcerative colitis.

ASACOL mesalazine 400 mg enteric coated tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

asacol mesalazine 400 mg enteric coated tablets blister pack

chiesi australia pty ltd - mesalazine, quantity: 400 mg - tablet, enteric coated - excipient ingredients: lactose monohydrate; sodium starch glycollate type a; magnesium stearate; purified talc; povidone; methacrylic acid copolymer; triethyl citrate; iron oxide yellow; iron oxide red; macrogol 6000 - for the treatment of mild to moderate ulcerative colitis and maintenance of remission in adults.